Status:
COMPLETED
Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or p...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- PLwO:
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, aged above or equal to 18 years at the time of signing informed consent
- Lives in mainland China and is native Chinese
- Current BMI based on self-reported height and weight of at least 28 kg/m\^2 as per mainland China definition of obesity(16) (calculated using an algorithm within the survey instrument)
- HCPs:
- Informed consent obtained before any study related activities (study-related activities are any procedure related to recording/collection of data according to the protocol)
- Male or female, aged greather than or equal to18 years at the time of signing informed consent.
- Physician with a license to practice
- Specialty is not surgeon (including general, bariatric or plastic surgeon)
- Practices in mainland China with at least 5 years in clinical practice
- Spends at least 50% of time in direct patient care (as opposed to surgical procedures, office procedures or research/administrative tasks)
- Has seen at least 100 patients in the past month
- Has seen at least 10 patients needing weight management (defined as a patient with a BMI greather than or equal to28 kg/m\^2 with or without comorbidities) in the past month
- Exclusion criteria:
- PLwO
- 1\. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation HCPs
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Unwillingness, inability, or language barriers precluding adequate understanding or cooperation
Exclusion
Key Trial Info
Start Date :
August 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT05428501
Start Date
August 18 2022
End Date
November 30 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Beijing, China